DE68920265D1 - Verfahren zur Enantiomerentrennung von Cis-3-amino-4-[2-(2-furyl)vinyl]-1-methoxycarbonylmethyl-azetidin-2-on und deren Di-p-Toluoyl-Weinsäuresalze. - Google Patents

Verfahren zur Enantiomerentrennung von Cis-3-amino-4-[2-(2-furyl)vinyl]-1-methoxycarbonylmethyl-azetidin-2-on und deren Di-p-Toluoyl-Weinsäuresalze.

Info

Publication number
DE68920265D1
DE68920265D1 DE68920265T DE68920265T DE68920265D1 DE 68920265 D1 DE68920265 D1 DE 68920265D1 DE 68920265 T DE68920265 T DE 68920265T DE 68920265 T DE68920265 T DE 68920265T DE 68920265 D1 DE68920265 D1 DE 68920265D1
Authority
DE
Germany
Prior art keywords
methoxycarbonylmethyl
azetidin
furyl
vinyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68920265T
Other languages
English (en)
Other versions
DE68920265T2 (de
Inventor
John Brennan
Thomas Michael Eckrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE68920265D1 publication Critical patent/DE68920265D1/de
Publication of DE68920265T2 publication Critical patent/DE68920265T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE68920265T 1988-10-17 1989-10-12 Verfahren zur Enantiomerentrennung von Cis-3-amino-4-[2-(2-furyl)vinyl]-1-methoxycarbonylmethyl-azetidin-2-on und deren Di-p-Toluoyl-Weinsäuresalze. Expired - Fee Related DE68920265T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/258,918 US4931557A (en) 1988-10-17 1988-10-17 Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof

Publications (2)

Publication Number Publication Date
DE68920265D1 true DE68920265D1 (de) 1995-02-09
DE68920265T2 DE68920265T2 (de) 1995-05-24

Family

ID=22982690

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68920265T Expired - Fee Related DE68920265T2 (de) 1988-10-17 1989-10-12 Verfahren zur Enantiomerentrennung von Cis-3-amino-4-[2-(2-furyl)vinyl]-1-methoxycarbonylmethyl-azetidin-2-on und deren Di-p-Toluoyl-Weinsäuresalze.

Country Status (12)

Country Link
US (1) US4931557A (de)
EP (1) EP0365213B1 (de)
JP (1) JPH02169588A (de)
KR (1) KR900006322A (de)
AT (1) ATE116314T1 (de)
CA (1) CA1280431C (de)
DE (1) DE68920265T2 (de)
ES (1) ES2065396T3 (de)
GR (1) GR3015499T3 (de)
HU (1) HU207516B (de)
IE (1) IE65190B1 (de)
IL (1) IL91958A0 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030725A (en) * 1990-02-06 1991-07-09 Eli Lilly And Company Method of resolving cis 3-amino-4-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one using (-)-DAG
FR2664600B1 (fr) * 1990-07-16 1994-09-02 Rhone Poulenc Sante Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
MX9605611A (es) * 1994-05-16 1998-05-31 Merrell Pharma Inc Procedimiento y sales diastereomericas utiles para la resolucion optica de a-(4-(1,1-dimetiletil)fenil)-4-(hidroxidifenil-metil)-1-pipe ridinbutanol racemico y compuestos derivados.
IL142218A0 (en) * 1998-09-23 2002-03-10 Lonza Ag PROCESS FOR THE PREPARATION OF (-) -α- DIFLUORMETHYLORNITHINE MONOHYDROCHLORIDE MONOHYDRATE
CN101468986B (zh) * 2007-12-26 2010-12-29 香港南北兄弟国际投资有限公司 一种二氢嘧啶消旋化合物的拆分方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003913A (en) * 1973-07-09 1977-01-18 Ayerst Mckenna And Harrison Ltd. Pyrano- and thiopyranoindole derivatives, compositions and methods of use
GB1427097A (en) * 1973-10-18 1976-03-03 Ici Ltd Optically-active morpholine derivatives
US4072698A (en) * 1976-12-02 1978-02-07 The Upjohn Company Resolution of aminonitriles
IN148930B (de) * 1977-09-19 1981-07-25 Hoffmann La Roche
DE3410380A1 (de) * 1984-03-21 1985-10-10 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München S(-)-celiprolol, dessen pharmazeutisch vertraegliche salze, verfahren zu dessen herstellung, verwendung in der therapie und pharmazeutische zubereitungen
US4665171A (en) * 1985-07-17 1987-05-12 Harvard University Process and intermediates for β-lactam antibiotics

Also Published As

Publication number Publication date
ATE116314T1 (de) 1995-01-15
ES2065396T3 (es) 1995-02-16
HU895326D0 (en) 1990-01-28
HU207516B (en) 1993-04-28
DE68920265T2 (de) 1995-05-24
GR3015499T3 (en) 1995-06-30
KR900006322A (ko) 1990-05-07
JPH02169588A (ja) 1990-06-29
CA1280431C (en) 1991-02-19
IL91958A0 (en) 1990-07-12
EP0365213A2 (de) 1990-04-25
US4931557A (en) 1990-06-05
EP0365213A3 (de) 1991-11-06
IE65190B1 (en) 1995-10-04
IE893323L (en) 1990-04-17
EP0365213B1 (de) 1994-12-28
HUT58076A (en) 1992-01-28

Similar Documents

Publication Publication Date Title
IT8520036A0 (it) Processo per la preparazione biotecnologica di acidi alfa-arilalcanoici otticamente attivi.
DE3680132D1 (de) Verfahren zur herstellung von optisch aktiver indolin-2-carbonsaeure.
DE3686502D1 (de) Verfahren zur herstellung von optisch aktivem 2-halo-phenyl-ethanol.
DE3752086T2 (de) Verfahren zur Herstellung von optisch-aktiven Cyclopropancarbonsäure
DE3683512D1 (de) Verfahren zur optischen isomerisierung von optisch aktiver aminosaeure und verfahren zur herstellung von optisch aktiver aminosaeure.
DE3668884D1 (de) Verfahren zur optischen trennung von dl-cystein und (r,s)-1-(1-naphthyl)ethylamin.
ATE116313T1 (de) Verfahren zur auflösung von cis 3-amino-4-(2-(2- furyl)eth-1-yl>-1-methoxycarbonylmethyl-azetidi - 2-on und deren maleinsäuresalze.
DE68920265T2 (de) Verfahren zur Enantiomerentrennung von Cis-3-amino-4-[2-(2-furyl)vinyl]-1-methoxycarbonylmethyl-azetidin-2-on und deren Di-p-Toluoyl-Weinsäuresalze.
DE59104247D1 (de) Verfahren zur Racemisierung von optisch aktiven 1-Aryl-alkylaminen.
DE69107410D1 (de) Verfahren zur Herstellung von optischen aktiven Aminen.
DE3787958T2 (de) Abkömmlinge von (trans)- und 13-(cis)-Retionsäure sowie Verfahren zur Herstellung derselben.
DE69032341T2 (de) Verfahren zur Herstellung von optisch aktiven Verbindungen mit mehrfachen chiralen Mittelpunkten
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
DE3781749D1 (de) Herstellungsverfahren von optisch aktiven alkoholen.
IT8419782A0 (it) Processo per la preparazione di acidi alfa-arilalcanoici otticamente attivi.
DE3779456D1 (de) Verfahren zur herstellung von optisch aktiven aminen.
DE59007763D1 (de) Verfahren zur asymmetrischen Hydrierung von alpha-Ketocarbonyl-verbindungen zu optisch aktiven alpha-Hydroxycarbonylverbindungen.
IT8419783A0 (it) Processo per la preparazione di acidi alfa-arilalcanoici otticamente attivi.
DE58907892D1 (de) Verfahren zur Herstellung von optisch aktiven alpha-Aminoacetalen.
IT8622822A0 (it) Otticamente attivi. processo stereoconvergente per lapreparazione di acidi carbossilici
DE3889441T2 (de) Katalytisches Verfahren zur Herstellung von optisch aktivem Threonin.
DE68910033T2 (de) Katalytisches Verfahren zur Herstellung von optisch-aktiven Alpha-Hydroxycarboxylaten.
DE69015907D1 (de) Verfahren zur optischen Trennung von Dropropizin.
DE3851942T2 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.
DE68907771D1 (de) Pentafluorphenylderivate, verfahren zu deren herstellung einschliesslich der optisch aktiven derivate und verfahren zur optischen aufspaltung von chiralen carbonsaeuren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee